![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Sellmer, Laura; Kovács, Julia; Walter, Julia; Kumbrink, Jörg; Neumann, Jens; Kauffmann-Guerrero, Diego; Kiefl, Rosemarie; Schneider, Christian; Jung, Andreas; Behr, Jürgen und Tufman, Amanda
(27. Juni 2022):
Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC.
In: Frontiers in Immunology, Bd. 13
[PDF, 1MB]
Walter, Julia; Sellmer, Laura; Kahnert, Kathrin; Kiefl, Rosemarie; Syunyaeva, Zulfiya; Kauffmann-Guerrero, Diego; Manapov, Farkhad; Schneider, Christian; Behr, Juergen und Tufman, Amanda
(29. Januar 2022):
Consequences of the COVID-19 pandemic on lung cancer care and patient health in a German lung cancer center: results from a cross-sectional questionnaire.
In: Respiratory Research, Bd. 23
[PDF, 1MB]
Mertsch, Pontus; Götschke, Jeremias; Walter, Julia; Mümmler, Carlo; Ghiani, Alessandro; Schürmann, Ulrike; Kiefl, Rosemarie; Huber, Rudolf Maria; Behr, Jürgen; Kneidinger, Nikolaus und Milger, Katrin
(2022):
Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatment.
In: World Allergy Organization Journal, Bd. 15, Nr. 10
[PDF, 690kB]
Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Kiefl, Rosemarie; Sellmer, Laura; Walter, Julia; Behr, Jürgen und Tufman, Amanda
(2021):
Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study.
In: Scientific reports, Bd. 11, Nr. 1, 10919
[PDF, 2MB]
Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Kiefl, Rosemarie; Sellmer, Laura; Walter, Julia; Behr, Jürgen und Tufman, Amanda
(2021):
Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study.
In: Scientific Reports, Bd. 11, Nr. 1, 10919
Liu, Dong; Liu, Xiao-qing; Kiefl, Rosemarie; Zhang, Wei; Xu, Yin-hui und Tufman, Amanda
(2021):
Effects of the NF-kappa B Pathway Agonist IL-1 beta on Non-Small Cell Lung Cancer Cell Lines.
In: Annals of Clinical and Laboratory Science, Bd. 51, Nr. 3: S. 295-301
Liu, Yichao; Huber, Rudolf M.; Kiefl, Rosemarie; Tufman, Amanda und Kauffmann-Guerrero, Diego
(2020):
Hedgehog Pathway Activation Might Mediate Pemetrexed Resistance in NSCLC Cells.
In: Anticancer Research, Bd. 40, Nr. 3: S. 1451-1458
Liu, Xiaoqing; Tufman, Amanda; Behr, Jürgen; Kiefl, Rosemarie; Goldmann, Torsten und Huber, Rudolf M.
(2020):
Role of the erythropoietin receptor in Lung Cancer cells: erythropoietin exhibits angiogenic potential.
In: Journal of Cancer, Bd. 11, Nr. 20: S. 6090-6100
Berliner, Dominik; Mattern, Sarah; Wellige, Mareike; Malsch, Carolin; Gueder, Guelmisal; Brenner, Susanne; Morbach, Caroline; Deubner, Nikolas; Breunig, Margret; Kiefl, Rosemarie; Angermann, Christiane E.; Ertl, Georg; Schacky, Clemens von und Stoerk, Stefan
(2019):
The omega-3 index in patients with heart failure: A prospective cohort study.
In: Prostaglandins Leukotrienes and Essential Fatty Acids, Bd. 140: S. 34-41
Schacky, Clemens von; Passow, Adrian und Kiefl, Rosemarie
(2017):
Trans-fatty acid levels in erythrocytes in Europe.
In: European Journal of Nutrition, Bd. 56, Nr. 4: S. 1719-1723
Tufman, Amanda; Huber, Rudolf Maria; Volk, Stefanie; Aigner, Frederic; Edelmann, Martin; Gamarra, Fernando; Kiefl, Rosemarie; Kahnert, Kathrin; Tian, Fei; Boulesteix, Anne-Laure; Endres, Stefan und Kobold, Sebastian
(2016):
Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases.
In: BMC Cancer, Bd. 16: S. 409
Liu, Xiao-qing; Kiefl, Rosemarie; Roskopf, Claudia; Tian, Fei und Huber, Rudolf M.
(2016):
Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression.
In: PLOS ONE 11(5), e0156268 [PDF, 1MB]
In: PLOS ONE 11(5), e0156268 [PDF, 1MB]
Tian, Fei; Kiefl, Rosemarie; Tufman, Amanda und Huber, Rudolf
(2016):
The Hedgehog Pathway Inhibitor GDC-0449 Alters the Expression Level of the Pathway Components In Lung Cancer Cell Lines.
In: Chest, Bd. 149, Nr. 4:
299A-299A